Pure Global

Unconjugated Estriol (Maglumi Unconjugated Estriol ) - India CDSCO Medical Device Registration

Unconjugated Estriol (Maglumi Unconjugated Estriol ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000151_ccdb70055b817b660be8b7475f5af163_898eaeeecf054adb131152fbe8813677. This device is marketed under the brand name CLIA. The license holder is Medispace Solutions, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Unconjugated Estriol (Maglumi Unconjugated Estriol )
UID: IMP/IVD/2022/000151_ccdb70055b817b660be8b7475f5af163_898eaeeecf054adb131152fbe8813677

Brand Name

CLIA

License Holder

Medispace Solutions

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescence immunoassay for the quantitative determination of Unconjugated Estriol (CLIA) in human serum and plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing